ClinicalTrials.gg
RecruitingNCT05555693Updated Sep 27, 2022

Correlation Between Postoperative Cognitive-related Adverse Reactions and Brain Metabolomic Characteristics in Elderly Patients

An observational study in POCD - Postoperative Cognitive Dysfunction, sponsored by Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University. Recruiting at 1 site in China. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2022-09-27.

Sponsored by Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University · Observational

How we know

From the registry’s dates

  • Started Jul 2022; still recruiting 4 years 3 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
200
Ages
65 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 57 studies in Postoperative Cognitive Complications with a site in China — 14 open to participants now, 16 under way, none of them phase 3. Postoperative Cognitive Complications · China.

Planned enrollment
14th of 24
200 · median 213
Started
2022
with 4 others
Observational
24 of 57
7 open now
Primary completion
2027-01
later than 11 of 15 live
Registered
42nd of 57
by date

Among the 57 studies in Postoperative Cognitive Complications with a site in China, this one is the 14th largest by planned enrollment of the 24 observational ones that give a count, is one of 5 that started in 2022, is one of 24 observational ones, reaches primary completion later than 11 of the 15 other live ones, and was the 42nd registered.

Postoperative Cognitive Complications

261 studies on the registry are indexed under Postoperative Cognitive Complications; 56 are open to participants now.

Browse Postoperative Cognitive Complications studies →

Open to participants now

14 of the 57 studies in Postoperative Cognitive Complications with a site in China are open now. Recruiting first, the newest first:

8 more — sign in →

All 14 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 34 Postoperative Cognitive Complications studies recruiting now, 22 (65%) set no upper age limit and 4 (12%) stop at 75 or younger; 2 take children under 18; 6 take healthy volunteers.

This study: 65 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 57 studies in Postoperative Cognitive Complications with a site in China, or all of them as a file.
02

Study summary

Postoperative cognitive dysfunction (POCD) refers to the difficulties of orientation, cognition, communication, memory and abstract thinking of patients after anesthesia and surgery. And/or accompanied by the decline of the ability in social activities, such as the change of personality, social ability of language and behavior, cognitive function and life skills. POCD is a common complication of central nervous system in elderly patients after operation, with an early incidence of about 21% and a long-term incidence of about 35% . According to the current research on Alzheimer's disease (AD) and POCD in the elderly, it has been found that they have similar pathological basis and some homologous related genes. Altogether, POCD is closely related to molecular pathway neuropsychiatric diseases (such as dementia, depression and Alzheimer's disease). Researchers have come up with various hypotheses to reveal the underlying mechanisms of POCD, including neuritis, oxidative stress, autophagy disorder, synaptic dysfunction, and lack of neurotrophic support. To date, apart from evaluating with scales, CT Scan and EEG analysis, there is neither exact biomarkers for monitoring and diagnosing POCD, nor clear relationships between specific Brain Metabolomic Characteristics, EEG changes and diagnosis of POCD, so that the diagnosis of early POCD only stays in the evaluation of clinical symptoms and scales. Therefore, our study aims to provide an effective basis for early diagnosis and treatment of clinical POCD through multivariate analyses of clinical scales combined with Brain Metabolomic Characteristics, EEG analysis of patients.

03

Conditions studied

  • POCD - Postoperative Cognitive Dysfunction
04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Our research is a single center, nested case-control study. Preoperatively collect the information of the elderly patients over 65 years old without undergoing craniocerebral operations, including the vital signs, the examination reports and other related data after excluding the factors that can't be included in the group. The patients' health scales and preoperative cognitive function scales were evaluated.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 65 years or older .
  • Complete the operation in our hospital
  • I-II level
  • Agree to participate in this research and agree to sign an form

Exclusion criteria

Exclusion Criteria:

  • History of preoperative psychosis and psychotropic drug use
  • The subject is diagnosed with AD;
  • Abnormal preoperative mental scale assessment
  • Have a history of emergency rescue during the perioperative period
  • metal implants
  • Postoperative immobilization patients
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
200 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients in the control group were followed up without POCD postoperatively.

    If the MOCA or MMSE assessment all show a negative resluts at all time point.

    Other: Collecting clinical data, EGG,Brain Metabolomic Characteristics(with Magnetic Resonance Spectroscopy), blood gas data and blood sample

  • Patients in the case group were followed up with POCD postoperatively.

    If the MOCA assessment is positive at any time point after surgery, and there is a positive MMSE at any time point after surgery(no need for both MOCA and MMSE to be positive at the same time

    Other: Collecting clinical data, EGG,Brain Metabolomic Characteristics(with Magnetic Resonance Spectroscopy), blood gas data and blood sample

Interventions

  • OtherCollecting clinical data, EGG,Brain Metabolomic Characteristics(with Magnetic Resonance Spectroscopy), blood gas data and blood sample

    Collecting clinical data(before induction of anesthesia and first day after surgery), EGG(first day after surgery),Magnetic Resonance Spectroscopy data (before induction of anesthesia and first day after surgery)blood gas data(before induction of anesthesia and first day after surgery) and blood sample (before induction of anesthesia and first day, third day and 7th day after surgery)

06

What researchers measure

Primary outcomes

  1. MMSE (mini-mental state examiniation)

    MMSE scale score, If the MMSE assessment is positive at any time point, and there is a positive MMSE at any time point (no need for both MOCA and MMSE to be positive at the same time), it is defined as the occurrence of POCD.

    Time frame: 1 day after surgery

  2. MMSE (mini-mental state examiniation)

    MMSE scale score, If the MMSE assessment is positive at any time point, and there is a positive MMSE at any time point (no need for both MOCA and MMSE to be positive at the same time), it is defined as the occurrence of POCD.

    Time frame: immediately before surgery

  3. MMSE (mini-mental state examiniation)

    MMSE scale score, If the MMSE assessment is positive at any time point, and there is a positive MMSE at any time point (no need for both MOCA and MMSE to be positive at the same time), it is defined as the occurrence of POCD.

    Time frame: 3 day after surgery

  4. MMSE (mini-mental state examiniation)

    MMSE scale score, If the MMSE assessment is positive at any time point, and there is a positive MMSE at any time point (no need for both MOCA and MMSE to be positive at the same time), it is defined as the occurrence of POCD.

    Time frame: 7 day after surgery

  5. MOCA (Montreal Cognitive Assessment)

    MOCA sacle score, If the MOCA assessment is positive at any time point, and there is a positive MMSE at any time point (no need for both MOCA and MMSE to be positive at the same time), it is defined as the occurrence of POCD.

    Time frame: 1 day after surgery

  6. MOCA (Montreal Cognitive Assessment)

    MOCA sacle score, If the MOCA assessment is positive at any time point, and there is a positive MMSE at any time point (no need for both MOCA and MMSE to be positive at the same time), it is defined as the occurrence of POCD.

    Time frame: 3 day after surgery

  7. MOCA (Montreal Cognitive Assessment)

    MOCA sacle score, If the MOCA assessment is positive at any time point, and there is a positive MMSE at any time point (no need for both MOCA and MMSE to be positive at the same time), it is defined as the occurrence of POCD.

    Time frame: 7 day after surgery

  8. MOCA (Montreal Cognitive Assessment)

    MOCA sacle score, If the MOCA assessment is positive at any time point, and there is a positive MMSE at any time point (no need for both MOCA and MMSE to be positive at the same time), it is defined as the occurrence of POCD.

    Time frame: immediately before surgery

Secondary outcomes

  1. 3D-CAM

    3D-CAM score

    Time frame: 1 day after surgery

  2. Self-Rating Anxiety Scale

    Self-Rating Anxiety Scale score

    Time frame: immediately before surgery

  3. Self-rating depression scale

    Self-rating depression scale score

    Time frame: immediately before surgery

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2022 (actual). Primary completion is estimated for Jan 2027, 53 months after the start.

Of 76 non-industry observational studies under Postoperative Cognitive Complications, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 65. This study's planned 53 months is above that.

Counting every sponsor, half of 76 studies reached it within 27 months; a quarter within 11 and three quarters within 65.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 22, 2022
First posted
Sep 27, 2022
StartActual
Jul 27, 2022
Primary completionEst.
Jan 1, 2027
CompletionEst.
Dec 1, 2027
Last update
Sep 27, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 27, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05555693
Responsible party
Sponsor
First posted
Sep 27, 2022
Start date
Jul 27, 2022
Primary completion
Jan 1, 2027 (estimated)
Completion
Dec 1, 2027 (estimated)
Last update
Sep 27, 2022

Study contacts

Ren Zhou, PhD
Contact
zhouren77@126.com
15121007303

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion